Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 27, 2025
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial
Cas Stefaan Dejonckheere, Younèss Nour, Jörg Sahlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
Ebiomedicine
|
May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN
Stefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
The Lancet. Oncology
|
March 16, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 26, 2021
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Eleni Gkika, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Cancers
|
November 18, 2020
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry
Nika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
Nuklearmedizin. Nuclear Medicine
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
European Urology
|
May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 27, 2025
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial
Cas Stefaan Dejonckheere, Younèss Nour, Jörg Sahlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
Ebiomedicine
|
May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN
Stefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
The Lancet. Oncology
|
March 16, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 26, 2021
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Eleni Gkika, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Cancers
|
November 18, 2020
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry
Nika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
Nuklearmedizin. Nuclear Medicine
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
European Urology
|
May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 9